Concurrent protective and destructive signaling of JNK2 in neuroblastoma cells

Vicki Waetzig1, Ute Wacker, Wiebke Haeusgen

  • 1Institute of Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Hospitalstrasse 4, Kiel, Germany.

Cellular Signalling
|April 23, 2009
PubMed

Insights

The study reveals that c-Jun N-terminal kinases (JNKs) can simultaneously promote cell survival and trigger apoptosis. Specifically, JNK2 isoforms regulate both cell cycle progression and cell death in neuroblastoma cells, impacting cancer therapy strategies.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • c-Jun N-terminal kinases (JNKs) are known for their role in stress response and apoptosis, crucial for chemotherapy.
  • JNK signaling also contributes to physiological processes in cancer, including cell cycle regulation and oncogenesis.
  • The specific functions of JNKs are hypothesized to depend on their signalosome composition, leading to diverse outcomes.

Purpose of the Study:

  • To differentiate between the pro-apoptotic and physiological roles of JNKs in cancer.
  • To investigate how JNK signalosome composition influences signaling outcomes.
  • To elucidate the distinct functions of JNK isoforms in response to cytoskeleton-disrupting agents.

Main Methods:

  • Utilized the human neuroblastoma cell line SH-SY5Y as a model system.
  • Employed cytoskeleton-interfering substances: colchicine, cytochalasin D, and taxol.
  • Applied JNK inhibition using SP600125, compartment-specific inhibitors, and dominant-negative mutants.

Main Results:

  • JNKs were found to mediate both cell death and proliferation.
  • Nuclear JNK2 was identified as the primary mediator of apoptosis induced by colchicine and taxol.
  • Both cytoplasmic and nuclear JNK2 contributed to cell cycle promotion.
  • Apoptosis induced by cytochalasin D was independent of JNK signaling.
  • Demonstrated simultaneous control of cell-protective and cell-destructive mechanisms by a single JNK isoform.

Conclusions:

  • JNK signaling exhibits dual roles, mediating both cell survival and apoptosis within the same cellular context.
  • The localization and isoform of JNK (specifically JNK2) are critical determinants of its function.
  • Findings have significant implications for the therapeutic use of JNK inhibitors and cytoskeleton-targeting drugs in oncology.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...